Factors Predictive of Tumor Recurrence and Survival After Initial Complete Response of Esophageal Squamous Cell Carcinoma to Definitive Chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 1, 2010, Pages 123-129

  Ishihara, Ryu ^a   Yamamoto, Sachiko ^a   Iishi, Hiroyasu ^a   Takeuchi, Yoji ^a   Sugimoto, Naotoshi ^a   Higashino, Koji ^a   Uedo, Noriya ^a   Tatsuta, Masaharu ^a   Yano, Masahiko ^a   Imai, Atsushi ^a   Nishiyama, Kinji ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Chemoradiotherapy; Complete response; Esophageal cancer; Prognostic factor; Squamous cell type

Indexed keywords

CELL TYPES; CHEMORADIOTHERAPY; COMPLETE RESPONSE; ESOPHAGEAL CANCER; PROGNOSTIC FACTORS;

DECISION MAKING; FLUORESCENT SCREENS; PLATINUM COMPOUNDS; TELEVISION PICTURE TUBES; TUMORS;

MULTIVARIANT ANALYSIS;

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 72049099601     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.038     Document Type: Article

References (20)

1. World Health Organization. The world health report 1997 (1997), WHO, Geneva
2. Enzinger P.C., and Mayer R.J. Esophageal cancer. N Engl J Med 349 (2003) 2241-2252
3. Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 20 (2002) 1167-1174
4. Stahl M., Stuschke M., Lehmann N., et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
5. Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
6. Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281 (1999) 1623-1627
7. Smith T.J., Ryan L.M., Douglass Jr. H.O., et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42 (1998) 269-276
8. Ishikura S., Nihei K., Ohtsu A., et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21 (2003) 2697-2702
9. Tahara M., Ohtsu A., Hironaka S., et al. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol 35 (2005) 316-323
10. Japan Esophageal Society. Japanese classification of esophageal cancer. 10th ed. (2008), Kanehara, Tokyo
11. Dittler H.J., Pesarini A.C., and Siewert J.R. Endoscopic classification of esophageal cancer: Correlation with the T stage. Gastrointest Endosc 38 (1992) 662-668
12. Kienle P., Buhl K., Kuntz C., et al. Prospective comparison of endoscopy, endosonography and computed tomography for staging of tumours of the oesophagus and gastric cardia. Digestion 66 (2002) 230-236
13. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
14. Law S., Kwong D.L., Kwok K.F., et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: Impact of chemoradiation and change in treatment strategy. Ann Surg 238 (2003) 339-347
15. Vigneswaran W.T., Trastek V.F., Pairolero P.C., et al. Extended esophagectomy in the management of carcinoma of the upper thoracic esophagus. J Thorac Cardiovasc Surg 107 (1994) 901-906
16. Isono K., Sato H., and Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 48 (1991) 411-420
17. Denham J.W., Steigler A., Kilmurray J., et al. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 15 (2003) 98-108
18. Nousbaum J.B., Robaszkiewicz M., Cauvin J.M., et al. Endosonography can detect residual tumour infiltration after medical treatment of oesophageal cancer in the absence of endoscopic lesions. Gut 33 (1992) 1459-1461
19. Agarwal B., Swisher S., Ajani J., et al. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99 (2004) 1258-1266
20. Yano T., Muto M., Minashi K., et al. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 62 (2005) 31-36